ArticleWorld journal of surgical oncology2026
Surgical resection for sarcoma in the super-elderly: postoperative outcomes and clinical implications.
Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveJapan is one of the most rapidly aging societies worldwide, and the incidence of rare malignancies such as sarcoma is expected to rise among the very elderly. Chronological age often influences treatment decisions, but such bias may deprive patients of optimal management. Clarifying treatment outcome and prognostic factors in this population is essential for evidence-based treatment strategies. PATIENTS AND
methodsWe analyzed 21 patients aged 85 years or older who were diagnosed with sarcoma at our institution. Clinical characteristics, treatment modalities, and outcomes were reviewed. Univariate analyses were performed for categorical variables. Overall survival was estimated with the Kaplan–Meier method.
resultsThe mean age of the cohort was 87.6 years, and 20 patients (95.2%) underwent surgical resection. Radiotherapy was administered in 6 cases (30%), whereas no patients received chemotherapy. At the last follow-up, 15 patients were alive without disease, 2 were alive with disease, 3 had died of disease, and 1 had died of non–cancer-related causes. No statistically significant associations were identified, probably due to the limited sample size.
conclusionSurgical resection is feasible and can provide long-term benefit in selected patients aged 85 years or older with sarcoma. Analyses focusing on super-elderly patients indicated that refraining from surgery solely due to advanced age could potentially deprive patients of the benefits they may otherwise obtain. Thus, while age remains an important risk factor for surgical complications, individual decisions to perform tumor resection should be made with careful consideration of each patient’s overall condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.